FOX04-DRI 5mg

OVERVIEW

Equip your research workflow with FOX04-DRI (5mg) from Iron Labs — the Australian-stocked supplier of research-grade peptides led by our flagship Selank. FOX04-DRI is studied across biochemical and cellular research pipelines for its reproducibility, lyophilised stability, and ease of reconstitution. Each FOX04-DRI vial is synthesised in accredited peptide synthesis facilities and individually batch-tested for identity, purity, and consistency. Supplied as a 5mg lyophilised powder, FOX04-DRI pairs cleanly with the rest of our longevity & cellular research peptides catalogue for controlled experimental work.

KEY FEATURES

• High-purity FOX04-DRI research peptide
• 5mg lyophilised powder per vial
• HPLC-MS verified purity (99.79%)
• Synthesised in accredited laboratories
• Sterile tamper-evident vial
• Same-day dispatch, Australia-wide

SPECIFICATIONS

Product Name

FOX04-DRI 5mg

Peptide Grade

Research Grade

Quantity

5mg per vial

Form

Lyophilised powder

Purity

99.79% (HPLC-MS tested)

Appearance

White / off-white lyophilised powder

Storage

Cool, dry; refrigerate for long-term stability

Packaging

Sterile, tamper-evident vial

WHY CHOOSE SELANK AUSTRALIA

Iron Labs is the Australian-stocked supplier of research-grade peptides — Selank-led, but with the full bench available. Every FOX04-DRI batch is HPLC-MS verified for identity and purity, then dispatched Australia-wide via Australia Post Express in discreet packaging. Bulk pricing applies on multi-vial orders and support is available at support@ironlabs.com.au.